Rentschler Biopharma Marks Growth in Milford Site After U.S. Expansion

Rentschler Biopharma recently celebrated the progress of its U.S. site in Milford, Massachusetts, following a significant expansion. The site, established as a key element of the company's global strategy, now features the largest manufacturing expansion in its 150-year history. The fully operational site includes 22,000 square feet of cleanroom space and houses four 2,000 L single-use bioreactors.

The "Together We Build" event highlighted the site's achievements and its role within the company’s network. Massachusetts State Representative Brian W. Murray acknowledged the site’s economic and community contributions. Rentschler Biopharma’s Milford facility is noted for enhancing CDMO capabilities globally, emphasizing its tailored solutions for client projects in diverse therapeutic areas.